PISA 2020 Virtual Meeting
“Pathobiology That Drives Discovery, Diagnosis, and Treatment of Human Diseases: Present and Future”
Abstract Submission Deadline: CLOSED
The Organizing Committee reserves the right to reassign topic categories after review:
Atherosclerosis and Cardiovascular Disease
Cancer Niches and Developmental Pathway Signaling
Cardiac and Cardiovascular Pathobiology
Cell-Cell Communications and Exosomes
Cell Injury and Repair
Epithelial and Mucosal Pathobiology
Imaging, Immunohistochemistry, and Microscopy
Immunology, Immunity, and Immunotherapy
Neoplasia, Cancer Genomics, and Therapeutics
Abstract Submission Fees
- ASIP member or Guest Society member - $50.00 (US)
- Non-Member - $75.00 (US)
All PISA 2020 Virtual Meeting registered attendees are invited to submit an abstract using the Precis Online Abstract Management platform. All authors of submitted abstracts must adhere to the PISA 2020 Virtual Meeting Scientific Integrity Policy. Faxed, emailed or mailed abstracts will not be accepted. Accepted abstracts will be published ONLINE in The American Journal of Pathology (AJP) and in the online PISA 2020 Meeting Program.
First authors of accepted abstracts are expected to present a poster. Abstract-driven oral presentations will be scheduled into most or all platform sessions. I would reword to distinguish from a single special session.
Abstract Submission Requirements
- Complete abstracts must be submitted online no later than 11:59 PM (EDT) on Thursday, October 15, 2020. Changes to the abstract content or authors will be NOT accepted after the deadline. All abstracts must be submitted through use of the online abstract submission system. Faxed, emailed or mailed abstracts will not be accepted.
- Once an abstract is accepted, additional authors cannot be added.
- Notification of acceptance or rejection of the abstract will be e-mailed to the Presenting (First) Author by Monday, October 26, 2020.
- Product advertisements are not appropriate for presentation. ASIP reserves the right to exclude abstracts that promote commercial interests inappropriately or are viewed as unethical in content.
- ASIP reserves the right to withdraw a presentation at any time. .Abstracts will be published ONLINE in The AJP and in the online PISA 2020 Meeting Program.
- Poster presentations will be pre-recorded and the question and answer sessions will be asynchronous.The Presenting (First) Author is required to register and attend the PISA 2020 Virtual Meeting and will be responsible for recording his/her poster presentation. If the Presenting Author cannot attend the meeting, arrangements will be made for one of the Co-Authors to record the poster presentation.
- The Presenting Author verifies that all authors agree, and any supervisors have given permission, to the presentation of a scientific poster at the PISA 2020 Virtual Meeting and the inclusion of the abstract for onlinepublication.
- The Presenting Author is responsible for notifying all other authors of the acceptance, rejection, scheduling, and any other information provided by the ASIP.
- The Presenting Author is responsible to be in compliance with the PISA 2020 Virtual Meeting Scientific Integrity Policy.
- A Conflict of Interest Disclosure of Relevant Financial Relationships is required for each author of a submitted abstract. Each time an author is added during the online submission process, complete contact information and a Conflict of interest Disclosure of Relevant Financial Relationships specific to that author is required.
- By submitting an abstract (click “Create New”), the Presenting Author is agreeing to the following:
I have read, understand, and agree to the ASIP Rules for abstract submission and for the poster presentation layout and requirements. I understand that failure to adhere to these rules may result in denial of permission to present the abstract, disqualification for an award, and/or forfeiture of future rights to submit an abstract to future meetings.
Conflict of Interest Policy
The American Society for Investigative Pathology (ASIP) has implemented a process where everyone who is in a position to control the content of its scientific conferences must disclose all relevant financial relationships with any commercial interest and any conflicts of interest must be resolved prior to the meeting and available for review by the conference attendees so they may independently judge that the presented work is free from bias. Information will be reviewed by the ASIP Executive Officer; a determination will be made to manage any disclosed conflicts with safeguards against any potential bias. This is not intended to prevent participation unless the conflict of interest is determined to be unresolvable. Refusal to disclose means that you relinquish your ability to participate in PISA 2020 Virtual Meeting.
Circumstances create a conflict of interest when an individual has an opportunity to affect the educational content of the scientific conference about products or services of a commercial interest with which he/she has a financial relationship. The conflict of interest depends on the situation and not on the character or actions of the individual. Financial relationships are those relationships in which the individual or his/her spouse or partner benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (excluding diversified mutual funds), or other financial benefit; these are usually associated with roles such as employment, independent contractor (including contracted research), consulting, speaking and teaching, advisory/review panel or board membership, etc. A relevant financial relationship is one that creates a conflict of interest, in any amount, occurring in the 12 months before the individual assumes a role controlling educational content.
Abstract Formatting/Submission Instructions
Abstracts that are not submitted properly will receive an administrative reject and will not be reviewed.
- Abstracts must be submitted properly. The Precis online abstract management system is a database, with data fields (title, author 1, author 2, author 3, etc.) that are used to generate the published abstracts. Therefore, pay careful attention to the submission instructions and to the submission process, including spelling, capitalization, author names, etc.
- All abstracts must include the required headers listed below, so you will enter text under the appropriate header in the submission system.
- Introduction: A brief discussion of the background or rationale of the study and/or the question addressed
- Methods: The experimental approach, materials, and methods used in the study
- Results: The data and results obtained in the study
- Conclusions: The conclusions and/or implications of the results
- Language: The abstract must be written in English.
Presentation Format: In most cases, abstracts will be presented as a poster.
Title Case: Title must be initial caps throughout. Example: Molecular Mechanisms of Autophagy in Breast Cancer
- Abstract Limits:
- Number of authors: 15
- Abstract Title: 200 characters (including spaces)
- Abstract Content: 2,500 characters (with spaces and including section headers)
- You may include Greek letters and special symbols, e.g. ° (degree sign), ® (registered trademark), etc. However, the system will not accept or preserve tables or figures. Data must be reported in narrative format in the abstract submission.
- The scientific content of the abstract should contain new data that have not been previously published. Abstracts that are derivative of prior abstracts, reporting new incremental findings are acceptable.
- Authors may submit multiple abstracts.
- Confirmation: When you finish submitting your abstract, you will receive a confirmation screen verifying your submission and assigning a tracking number to your abstract. SAVE YOUR TRACKING NUMBER! It will serve as your identification number for corrections, scheduling, and notification and will be required if an application for a travel award is submitted.
- CORRECTIONS: If you must change your abstract, log in as a returning user with your email address and password. and click on the ID number of the abstract you wish to edit. DO NOT CREATE A NEW SUBMISSION.
- NOTE: You can edit your completed abstract an unlimited number of times until the deadline, for example, to add an author or correct spelling, etc. However, the last day to make changes of any kind is Wednesday, October 14, 2020.
- Your abstract will be rated using four criteria:
- Originality and Clarity
- Scientific Merit/Rigor
- Appropriate conclusions
- Summary: Grounds for abstract rejection are:
- Failure to follow directions in 1-5
- The abstract is not eligible for online publication in The AJP
- The abstract contains no scientific data and/or has only a promise of future data
- Duplicate abstracts are submitted
- The sponsor is not an ASIP Regular member or qualified Guest Society member. The sponsor or any author violated one of the stated ASIP rules for presentation
- The five most common reasons for rejection are:
- Abstract is composed completely of previously presented/published data
- Poor organization/clarity
- No novel information
- Insufficient scientific quality
- Insufficient data
- Additional reasons for administrative abstract rejection without review include:
- The use of all capital letters in the title (Title Case)
- Improper use of italics (i.e., genes should be italicized, not proteins)
- Overt endorsement and/or promotion of a product or service
- Submission of duplicate or highly replicative abstracts under different first author names
The submission and management of the posters will be handled and processed through our virtual meeting platform CONFEX. Additional information will be provided and posted on the PISA 2020 Virtual Meeting website in the coming weeks.
Please visit the PISA 2020 Virtual Meeting website (pisa20.asip.org) to view see specific information pertaining to award eligibility requirements and application instructions. Trainees who are the first author of an abstract who are also ASIP members may apply for Trainee Scholar Awards. Likewise, we will give some Junior Faculty Scholar Awards – the faculty member needs to be the corresponding author of an abstract and be within the time limit since their first faculty appointment that applies to travel awards. To be considered for the APSA Scholar Award, individuals must be a member of APSA in good standing.
You may apply for as many awards as you qualify for. The deadline to submit your award package is 11:59 (EDT) Thursday, October 15, 2020.
Applications are being considered for the following awards:
Junior Faculty Scholar Awards
- Dani and Erik Zander Junior Faculty Scholar Award
- George K. Michalopoulos Junior Faculty Scholar Award
- Monga-Hans Junior Faculty Scholar Award
Junior Faculty Scholar Awards will include a cash award and complimentary registration for the meeting.
ASIP Trainee Scholar Awards
- A.D. Sobel Trainee Scholar Award
- ASIP-APSA Partnership Trainee Scholar Award
- ASIP International Trainee Travel Scholar Award
- Gall Trainee Scholar Award for Excellence in Cardiovascular Research
- Gotlieb Undergraduate Student Scholar Award
- Histochemical Society (HCS) Trainee Scholar Award
- Marion and Lawrence (Larry) Muller Memorial Fund - ASIP Trainee Scholar Award for Excellence in Inflammation Research
- Marion and Lawrence (Larry) Muller Memorial Fund - ASIP Trainee Scholar Award for Excellence in Neurodegenerative Disease Research
- Monga-Hans Trainee Scholar Award for Excellence in Cardiovascular Research
- Monga-Hans Trainee Scholar Award for Excellence in Neoplasia Research
- Monga-Hans Trainee Scholar Award for Excellence in Liver Pathobiology Research
Trainee Scholar Awards include a cash award.